Circulation. 2005;112:1376-1378
doi: 10.1161/CIRCULATIONAHA.105.562777
(Circulation. 2005;112:1376-1378.)
© 2005 American Heart Association, Inc.
Protecting the Heart Against Arrhythmias: Potassium Current Physiology and Repolarization Reserve
Dan M. Roden, MD;
Tao Yang, PhD
From the Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn.
Correspondence to Dan M. Roden, MD, Director, Oates Institute for Experimental Therapeutics, Vanderbilt University School of Medicine, 532 Medical Research Building I, Nashville, TN 37232. E-mail dan.roden{at}vanderbilt.edu
Key Words: Editorials arrhythmia ion channels potassium repolarization
 |
Introduction
|
|---|
Hodgkin and Huxleys classic experiments in the squid
giant axon were the first to define a role for potassium efflux
as a mechanism to return the membrane potential of an excitable
cell to resting values.
1 They showed that depolarization was
caused by a rapid influx of sodium into the squid giant axon,
an event which then initiated movement of potassium from inside
the axon to the exterior. The resulting repolarizing current,
termed
IK, was identified decades later as a major contributor
to repolarization in heart cells.
2 IK appeared to not only drive
normal repolarization but also respond to adrenergic activation.
By the 1970s it was apparent that ß-adrenergic stimulation
markedly increases inward calcium current in myocytes
3; this
would prolong the QT interval on exercise were it not for a
"balancing" effect of
IK activation.
4
See p 1384 and 1392
 |
Separating IK Into IKr and IKs in Heart
|
|---|
In the late 1980s, there was some enthusiasm for the concept
that arrhythmias could be suppressed by drugs that selectively
delay repolarization (ie, without exerting other electrophysiological
effects such as sodium channel block). A number of potent QT-prolonging
agents were developed; in fact, 2dofetilide and ibutilidehave
reached clinical use. Studies of the molecular basis of such
selective action potential prolongation led to the key discovery
by Michael Sanguinetti, then at Merck, that "
IK" in guinea pig
myocytes actually represented 2 distinct currents: a small drug-sensitive
current that activated rapidly (hence, termed
IKr) and a large
drug-resistant currrent that activated slowly,
IKs.
5 IKr block
is now recognized as the overwhelmingly common mechanism whereby
drugs produce QT prolongation. Work by many laboratories has
defined key electrophysiological and pharmacological properties
of
IKr. Notably, the Sanguinetti laboratory has proposed a structural
basis for the peculiar "promiscuity" of
IKr to block not only
by antiarrhythmics but also by a wide range of "noncardiovascular"
agents such as antihistamines, antipsychotics, and antibiotics,
many of which have been relabeled or withdrawn because of risks
thought to be associated with QT interval prolongation.
68
The physiological and pharmacological separation of IKr and IKs were followed in the mid-1990s by the cloning of the genes whose expression generates these currents, and the identification of mutations in those genes as the commonest causes for the congenital long QT syndrome.911 Expression of HERG (now also known as KCNH2) is sufficient to recapitulate most properties of IKr, although ancillary function-modifying subunits have been proposed.12,13 By contrast, recapitulation of IKs requires coexpression not only of the gene encoding the pore-forming subunit, KCNQ1 (formerly known as KvLQT1), but also an important function-modifying protein, termed KCNE1 (or minK),14,15 which was initially cloned from a rat kidney cDNA library.16
 |
IKr Block Causes Torsade de Pointes, But Not Always
|
|---|
The vast majority of heart beats in patients with loss of function
mutations in
HERG are, in fact, normal and in many instances
even accompanied by normal QT intervals. Similarly, although
IKr block is now recognized as the major initiating mechanism
in drug-induced torsade de pointes, not every patient receiving
culprit drugs develops marked QT prolongation or the arrhythmia.
This lack of a simple relationship between reduced
IKr and a
manifest clinical phenotype tells us that risk can be modulated
by factor(s) beyond
IKr alone. Variable drug metabolism can
be invoked in some cases of drug-associated torsade de pointes
17 but this is far from a universal explanation and does not explain
variability in the congenital syndrome. To explain this variability
in response to reduction or block of
IKr, we proposed the concept
of "repolarization reserve."
18 We hypothesized that because
multiple mechanisms were increasingly recognized as contributing
to normal repolarization, loss of function in one of these (eg,
reduced
IKr) may not lead to clinical consequences unless other
lesions were present. Examples of such lesions are subclinical
mutations in ion channel or other genes or disordered electrogenesis
increasingly recognized in acquired diseases such as heart failure
or left ventricular hypertrophy. Two articles in this issue
of
Circulation provide evidence that
IKs may be a major source
of repolarization reserve that protects against torsade de points
during
IKr block.
19,20
 |
At First Glance, IKs Does Not Seem Large in Human Ventricular Myocytes
|
|---|
When long depolarizations are used to elicit outward current,
IKs can be huge; however, an appreciation of the role of
IKs under more physiological conditions, especially in larger mammals,
21 has been slower to evolve. Although both
IKr and
IKs have previously
been identified in voltage-clamped human heart cells,
22,23 their
relative contributions to repolarization have not been explored.
The laboratory of András Varró used relatively
specific
IKr and
IKs blockers as tools to probe this issue.
19 Whereas
IKr blockers routinely prolonged action potentials,
especially at slow rates (no surprise), it was a surprise that
none of the
IKs blockers did much at any stimulation rate. In
fact, direct measurement of the currents with depolarizations
approximating the human action potential duration showed that
IKr is much larger than
IKs; with longer depolarizations (one
way of simulating longer action potentials),
IKs did get a bit
bigger. One possible interpretation is that the current is not
important, but this is difficult to reconcile with the fact
that losing the current can be fatal because mutations in
KCNQ1 are the single most common cause of the congenital long QT syndrome.
24 Many explanations are possible: The specific cells studied may
not have had much
IKs (we know from work in canines that some
cells exhibit less
IKs than others), or
IKs may have been damaged
by the isolation procedure, or
IKs is only important when action
potentials get long, or, in fact,
IKs is not important under
basal conditions. The apparent paradox was partially resolved
by additional experiments demonstrating that when
IKr is blocked
and the cells are exposed to adrenalin,
IKs block prolonged
action potentials. There are 2 reasonable conclusions. The first
is that incorporating some basal sympathetic activity should
be strongly considered in any study of action potential control.
Indeed, in canine models,
IKs block produces little discernible
effect in the absence of catecholamines.
25,26 The second conclusion
is that
IKs protects against action potential prolongation when
IKr is blocked (ie, that it contributes to repolarization reserve).
 |
What Does KCNE1 Do to K+ Current to Make It IKs?
|
|---|
The problem of predicting how a complex system with multiple
interrelated elements (eg, action potential) responds to a change
in the behavior of an individual component is a general one
in systems biology. One approach is to evaluate the effects
of pharmacological probes (eg, blockers of specific components),
but often these are not available. The laboratory of Yoram Rudy
27 has devoted considerable effort to an alternate approach: incorporation
of physiological properties of individual components of the
action potential, such as
IKr,
IKs, inward currents, and intracellular
calcium control mechanisms, into a computational model of the
action potential, thereby allowing the effects of alterations
in individual components to be simulated over a wide range of
"in silico" experimental conditions. An issue that motivated
the study reported here by Silva and Rudy
20 was the question
of how currents generated by
KCNQ1 alone and by
KCNQ1 + KCNE1
(
IKs) differ as a function of rate. Action potentials and QT
intervals are shorter at fast rates, and a larger
IKs is thought
to be an important contributor, although the mechanism has been
uncertain. In guinea pig myocytes, a depolarizing pulse activates
IKs but with a delay, and with repolarization
IKs undergoes
deactivation, which is slow. These properties generated the
conventional wisdom that
IKs "accumulates" at fast rates because
slow deactivation prevents the current from returning completely
to baseline.
28 Such accumulation could certainly account for
shorter action potential duration and QT interval at fast rates,
as is observed physiologically. A fly in this ointment is that
IKs deactivation in other species such as the dog, is faster,
21 so the accumulation hypothesis needs closer reexamination.
Silva and Rudy have explored new state models for KCNQ1 and for KCNQ1 + KCNE1 to address this issue. The simplest model to explain the behavior of an ion channel is one in which the channel can occupy 1 of 2 states, closed or open, with state transitions described by individual rate constants. The observation that IKs activation occurs with depolarization, but only after a delay, suggests that the channel may move through multiple closed states before opening during a depolarization.29 Silva and Rudy used physiological data obtained from multiple previous reports to construct a much more complex view of KCNQ1 behavior alone and in presence of KCNE1 to generate IKs. The simulations strongly suggest that IKs accumulation at rapid rates is not caused by slow deactivation but rather by preferential occupancy of the channel in "proximal" closed states, very near the open one, at fast rates. When the channel exists in these proximal closed states, IKs can open with a minimal delay after a depolarization and rapidly become rather large. A particularly intriguing observation is that KCNQ1 alone cannot prevent an arrhythmogenic, pause-dependent early afterdepolarization, whereas IKs, by activating during the plateau potential, can. In this way, repolarization reserve is generated by coexpression of KCNE1 with KCNQ1. "States" in models such as these represent either biophysical abstractions or, conceivably, individual conformations of the dynamic behaviors of these proteins. As Silva and Rudy are at pains to point out, although the results from the model are provocative, interesting, and physiologically rational, they are hypothesis-generating until additional physiological studies, which they even outline, address them.
 |
Approaches to the Study of Complex Biological Systems
|
|---|
Taken together, the studies suggest that an important role of
IKs in the human heart is to protect against pathological action
potential prolongation (ie, to provide repolarization reserve).
More generally, "repolarization reserve" is shorthand for the
much broader concept that physiological systems often include
considerable redundancies, and that these can protect against
manifest disease phenotypes arising from a single lesion. This
concept has wide applicability not only in cardiovascular medicine
but also it is familiar as the "multiple" hit hypotheses in
cancer biology. The 2
IKs-focused article in this weeks
issue of
Circulation serve to reiterate the message that unraveling
such complex systems biology requires multiple highly complementary
approaches, including a focus on individual molecules, integrated
physiological behaviors, and appropriately constructed computational
models to validate current hypotheses and to point to new experiments.
 |
Acknowledgments
|
|---|
This work was supported in part by grants from the US Public
Health Service (HL46681, HL49989, HL65962) and the American
Heart Association (0565306B). Dr Roden is the holder of the
William Stokes Chair in Experimental Therapeutics, a gift from
the Dai-ichi Corporation.
 |
Footnotes
|
|---|
The opinions expressed in this article are not necessarily those
of the editors or of the American Heart Association.
 |
References
|
|---|
- Hodgkin AL, Huxley AF. Currents carried by sodium and potassium ions through the membrane of the giant axon of Loligo. J Physiol (Lond). 1952; 116: 449472.[Free Full Text]
- McAllister RE, Noble D. The time and voltage dependence of the slow outward current in cardiac Purkinje fibres. J Physiol. 1966; 186: 632662.[Abstract/Free Full Text]
- Shigenobu K, Sperelakis N. Calcium current channels induced by catecholamines in chick embryonic hearts whose fast sodium channels are blocked by tetrodotoxin or elevated potassium. Circ Res. 1972; 31: 932952.[Abstract/Free Full Text]
- Bennett PB, McKinney L, Begenisich T, Kass RS. Adrenergic modulation of the delayed rectifier potassium channel in calf cardiac Purkinje fibers. Biophys J. 1986; 49: 839848.[Abstract/Free Full Text]
- Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K+ current: differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol. 1990; 96: 195215.[Abstract/Free Full Text]
- Mitcheson JS, Chen J, Lin M, Culberson C, Sanguinetti MC. A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci U S A. 2000; 97: 1232912333.[Abstract/Free Full Text]
- Viskin S, Justo D, Halkin A, Zeltser D. Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis. 2003; 45: 415427.[Medline]
[Order article via Infotrieve]
- Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004; 350: 10131022.[Free Full Text]
- Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995; 80: 795803.[CrossRef][Medline]
[Order article via Infotrieve]
- Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995; 81: 299307.[CrossRef][Medline]
[Order article via Infotrieve]
- Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996; 12: 1723.[CrossRef][Medline]
[Order article via Infotrieve]
- Petersen CI, McFarland TR, Stepanovic SZ, Yang P, Reiner DJ, Hayashi K, George AL, Roden DM, Thomas JH, Balser JR. In vivo identification of ether-a-go-go related gene-interacting proteins in Caenorhabditis elegans that affect cardiac arrhythmias in humans. Proc Natl Acad Sci U S A. 2004; 101: 1177311778.[Abstract/Free Full Text]
- Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, Goldstein SA. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999; 97: 175187.[CrossRef][Medline]
[Order article via Infotrieve]
- Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G. KvLQT1 and IsK (minK) proteins associate to form the IKs cardiac potassium current. Nature. 1996; 384: 7880.[CrossRef][Medline]
[Order article via Infotrieve]
- Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, Keating MT. Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel. Nature. 1996; 384: 8083.[CrossRef][Medline]
[Order article via Infotrieve]
- Takumi T, Ohkubo H, Nakanishi S. Cloning of a membrane protein that induces a slow voltage-gated potassium current. Science. 1988; 242: 10421045.[Abstract/Free Full Text]
- Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA. 1993; 269: 15321536.[Abstract]
- Roden DM. Taking the idio out of idiosyncraticpredicting torsades de pointes. Pacing Clin Electrophysiol. 1998; 21: 10291034.[CrossRef][Medline]
[Order article via Infotrieve]
- Jost N, Virag L, Bitay M, Takacs J, Lengyel C, Biliczki P, Nagy Z, Bogats G, Lathrop DA, Papp JG, Varro A. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle. Circulation. 2005; 112: 13921399.[Abstract/Free Full Text]
- Silva J, Rudy Y. Subunit interaction determines IKs participation in cardiac repolarization and repolarization reserve. Circulation. 2005; 112: 13841391.[Abstract/Free Full Text]
- Gintant GA. Two components of delayed rectifier current in canine atrium and ventricle: does IKs play a role in the reverse rate dependence of class III agents? Circ Res. 1996; 78: 2637.[Abstract/Free Full Text]
- Wang Z, Fermini B, Nattel S. Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res. 1994; 28: 15401546.[Medline]
[Order article via Infotrieve]
- Virag L, Iost N, Opincariu M, Szolnoky J, Szecsi J, Bogats G, Szenohradszky P, Varro A, Papp JG. The slow component of the delayed rectifier potassium current in undiseased human ventricular myocytes. Cardiovasc Res. 2001; 49: 790797.[CrossRef][Medline]
[Order article via Infotrieve]
- Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D. Risk stratification in the long-QT syndrome. N Engl J Med. 2003; 348: 18661874.[Abstract/Free Full Text]
- Shimizu W, Antzelevitch C. Cellular basis for the ECG features of the LQTt1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation. 1998; 98: 23142322.[Abstract/Free Full Text]
- Volders PG, Stengl M, van Opstal JM, Gerlach U, Spatjens RL, Beekman JD, Sipido KR, Vos MA. Probing the contribution of IKs to canine ventricular repolarization: key role for beta-adrenergic receptor stimulation. Circulation. 2003; 107: 27532760.[Abstract/Free Full Text]
- Luo CH, Rudy Y. A model of the ventricular cardiac action potential. Depolarization, repolarization, and their interaction. Circ Res. 1991; 68: 15011526.[Abstract/Free Full Text]
- Lu Z, Kamiya K, Opthof T, Yasui K, Kodama I. Density and kinetics of I(Kr) and I(Ks) in guinea pig and rabbit ventricular myocytes explain different efficacy of I(Ks) blockade at high heart rate in guinea pig and rabbit: implications for arrhythmogenesis in humans. Circulation. 2001; 104: 951956.[Abstract/Free Full Text]
- Balser JR, Bennett PB, Roden DM. Time-dependent outward current in guinea pig ventricular myocytes. Gating kinetics of the delayed rectifier. J Gen Physiol. 1990; 96: 835863.[Abstract/Free Full Text]
Related Articles:
-
Subunit Interaction Determines IKs Participation in Cardiac Repolarization and Repolarization Reserve
- Jonathan Silva and Yoram Rudy
Circulation 2005 112: 1384-1391.
[Abstract]
[Full Text]
-
Restricting Excessive Cardiac Action Potential and QT Prolongation: A Vital Role for IKs in Human Ventricular Muscle
- Norbert Jost, László Virág, Miklós Bitay, János Takács, Csaba Lengyel, Péter Biliczki, Zsolt Nagy, Gábor Bogáts, David A. Lathrop, Julius G. Papp, and András Varró
Circulation 2005 112: 1392-1399.
[Abstract]
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
L. Xiao, J. Xiao, X. Luo, H. Lin, Z. Wang, and S. Nattel
Feedback Remodeling of Cardiac Potassium Current Expression: A Novel Potential Mechanism for Control of Repolarization Reserve
Circulation,
September 2, 2008;
118(10):
983 - 992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ahmad and P. Dorian
Drug-induced QT prolongation and proarrhythmia: an inevitable link?
Europace,
September 1, 2007;
9(suppl_4):
iv16 - iv22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lengyel, L. Virag, T. Biro, N. Jost, J. Magyar, P. Biliczki, E. Kocsis, R. Skoumal, P. P. Nanasi, M. Toth, et al.
Diabetes mellitus attenuates the repolarization reserve in mammalian heart
Cardiovasc Res,
February 1, 2007;
73(3):
512 - 520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kijtawornrat, Y. Nishijima, B. M. Roche, B. W. Keene, and R. L. Hamlin
Use of a Failing Rabbit Heart as a Model to Predict Torsadogenicity
Toxicol. Sci.,
September 1, 2006;
93(1):
205 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Xiao, L. Zhang, W. Han, Z. Wang, and S. Nattel
Sex-based transmural differences in cardiac repolarization and ionic-current properties in canine left ventricles
Am J Physiol Heart Circ Physiol,
August 1, 2006;
291(2):
H570 - H580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Varro and J. Gy. Papp
Low penetrance, subclinical congenital LQTS: Concealed LQTS or silent LQTS?
Cardiovasc Res,
June 1, 2006;
70(3):
404 - 406.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Roden
A New Role for Calmodulin in Ion Channel Biology
Circ. Res.,
April 28, 2006;
98(8):
979 - 981.
[Full Text]
[PDF]
|
 |
|